{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:18:56Z","timestamp":1792725536535,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2006,10,4]],"date-time":"2006-10-04T00:00:00Z","timestamp":1159920000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Autism Dev Disord"],"published-print":{"date-parts":[[2007,2,22]]},"DOI":"10.1007\/s10803-006-0234-7","type":"journal-article","created":{"date-parts":[[2006,10,3]],"date-time":"2006-10-03T17:28:30Z","timestamp":1159896510000},"page":"367-373","source":"Crossref","is-referenced-by-count":117,"title":["Risperidone Improves Behavioral Symptoms in Children with Autism in a Randomized, Double-Blind, Placebo-Controlled Trial"],"prefix":"10.1007","volume":"37","author":[{"given":"Gahan J.","family":"Pandina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Bossie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriene","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Dunbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2006,10,4]]},"reference":[{"key":"234_CR1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.spen.2004.07.006","volume":"11","author":"M. G. Aman","year":"2004","unstructured":"Aman, M. G. (2004). Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Seminars in Pediatric Neurology, 11, 225\u2013228.","journal-title":"Seminars in Pediatric Neurology"},{"key":"234_CR2","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1017\/S1092852900008348","volume":"9","author":"M. G. Aman","year":"2004","unstructured":"Aman, M. G., Novotny, S., Samango-Sprouse, C., Lecavalier, L., Leonard, E., Gadow, K. D., et al. (2004). Outcome measures for clinical drug trials in autism. CNS Spectrums, 9, 36\u201347.","journal-title":"CNS Spectrums"},{"key":"234_CR3","first-page":"485","volume":"89","author":"M. G. Aman","year":"1985","unstructured":"Aman, M. G., Singh, N. N., Stewart, A. W., & Field, C. J. (1985). The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. American Journal of Mental Deficiency, 89, 485\u2013491.","journal-title":"American Journal of Mental Deficiency"},{"key":"234_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0891-4222(95)00039-9","volume":"17","author":"M. G. Aman","year":"1996","unstructured":"Aman, M. G., Tass\u00e9, M. J., Rojahn, J., & Hammer, D. (1996). The Nisonger CBRF: A child behavior rating form for children with developmental disabilities. Research in Developmental Disabilities, 17, 41\u201357.","journal-title":"Research in Developmental Disabilities"},{"key":"234_CR5","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","volume":"27","author":"American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity","year":"2004","unstructured":"American Diabetes Association; American Psychiatric Association; American Association of Clinical Endocrinologists; North American Association for the Study of Obesity. (2004). Consensus development conference on antipsychotic drugs and obesity and diabetes. Diabetes Care, 27, 596\u2013601.","journal-title":"Diabetes Care"},{"key":"234_CR6","volume-title":"Diagnostic and statistical manual of mental disorders","author":"American Psychiatric Association","year":"2000","unstructured":"American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders. Washington: American Psychiatric Press."},{"key":"234_CR7","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00004583-200312000-00011","volume":"42","author":"L. E. Arnold","year":"2003","unstructured":"Arnold, L. E., Vitiello, B., McDougle, C., Scahill, L., Shah, B., Gonzalez, N. M., et al. (2003). Parent-defined target symptoms respond to risperidone in RUPP autism study: Customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1443\u20131450.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"234_CR8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1023\/A:1026056518470","volume":"28","author":"A. S. Carter","year":"1998","unstructured":"Carter, A. S., Volmar, F. R., Sparrow, S. S., Wang, J. J., Lord, C., Dawson, G., et al. (1998). The Vineland Adaptive Behavioral Scales: Supplementary norms of individuals with autism. Journal of Autism and Developmental Disorders, 28, 287\u2013302.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"234_CR9","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.spen.2004.07.007","volume":"11","author":"M. G. Chez","year":"2004","unstructured":"Chez, M. G., Memon, S., & Hung, P. C. (2004). Neurologic treatment strategies in autism: An overview of medical intervention strategies. Seminars in Pediatric Neurology, 11, 229\u2013235.","journal-title":"Seminars in Pediatric Neurology"},{"key":"234_CR10","first-page":"233","volume":"7","author":"G. Chouinard","year":"1980","unstructured":"Chouinard, G., Ross-Chouinard, A., Annable, L., & Jones, B. D. (1980). Extrapyramidal symptom rating scale. The Canadian Journal of Neurological Sciences, 7, 233.","journal-title":"The Canadian Journal of Neurological Sciences"},{"key":"234_CR11","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1176\/appi.ajp.161.5.918","volume":"161","author":"F. Dunbar","year":"2004","unstructured":"Dunbar, F., Kusumakar, V., Daneman, D., & Schultz, M. (2004). Growth and sexual maturation during long-term treatment with risperidone. American Journal of Psychiatry, 161, 918\u2013920.","journal-title":"American Journal of Psychiatry"},{"key":"234_CR12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.4088\/JCP.v64n1113","volume":"64","author":"R. Findling","year":"2003","unstructured":"Findling, R., Kusumakar, V., Daneman, D., Moshang, T., De Smedt, G., & Binder, C. (2003). Prolactin levels during long-term risperidone treatment in children and adolescents. Journal of Clinical Psychiatry, 64, 1362\u20131369.","journal-title":"Journal of Clinical Psychiatry"},{"key":"234_CR13","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1023\/A:1025054610557","volume":"33","author":"E. Fombonne","year":"2003","unstructured":"Fombonne, E. (2003). Epidemiological surveys of autism and other pervasive developmental disorders: An update. Journal of Autism and Developmental Disorders, 33, 365\u2013382.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"234_CR14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1089\/104454604773840472","volume":"14","author":"A. Gagliano","year":"2004","unstructured":"Gagliano, A., Germano, E., Pustorino, G., Impallomeni, C., D\u2019Arrigo, C., Calamoneri, F., & Spina, E. (2004). Risperidone treatment of children with autistic disorder: Effectiveness, tolerability, and pharmacokinetic implications. Journal of Child and Adolescent Psychopharmacology, 14, 39\u201347.","journal-title":"Journal of Child and Adolescent Psychopharmacology"},{"key":"234_CR15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1023\/A:1020593922901","volume":"32","author":"R. H. Horner","year":"2002","unstructured":"Horner, R. H., Carr, E. G., Strain, P. S., Todd, A. W., & Reed, H. K. (2002). Problem behavior interventions for young children with autism: A research synthesis. Journal of Autism and Developmental Disorders, 32, 423\u2013446.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"234_CR16","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/00004583-200202000-00007","volume":"41","author":"R. P. Malone","year":"2002","unstructured":"Malone, R. P., Maislin, G., Choudhury, M. S., Gifford, C., & Delaney, M. A. (2002). Risperidone treatment in children and adolescents with autism: Short- and long-term safety and effectiveness. Journal of the American Academy of Child and Adolescent Psychiatry, 41, 140\u2013147.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"234_CR17","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.2165\/00023210-200418140-00006","volume":"18","author":"G. Masi","year":"2004","unstructured":"Masi, G. (2004). Pharmacotherapy of pervasive developmental disorders in children and adolescents. CNS Drugs, 18, 1031\u20131052.","journal-title":"CNS Drugs"},{"key":"234_CR18","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.4088\/JCP.v64n0909","volume":"64","author":"G. Masi","year":"2003","unstructured":"Masi, G., Cosenza, A., Mucci, M., & Brovedani, P. (2003). A 3-year naturalistic study of 53 preschool children with pervasive developmental disorders treated with risperidone. The Journal of Clinical Psychiatry, 64, 1039\u20131047.","journal-title":"The Journal of Clinical Psychiatry"},{"key":"234_CR19","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1056\/NEJMoa013171","volume":"347","author":"J. T. McCracken","year":"2002","unstructured":"McCracken, J. T., McGough, J., Shah, B., Cronin, P., Hong, D., Aman, M. G., et al., Research Units on Pediatric Psychopharmacology Autism Network. (2002). Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine, 347, 314\u2013321.","journal-title":"The New England Journal of Medicine"},{"key":"234_CR20","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1176\/appi.ajp.162.6.1142","volume":"162","author":"C. J. McDougle","year":"2005","unstructured":"McDougle, C. J., Scahill, L., Aman, M. G., McCracken, J. T., Tierney, E., Davies, M., et al. (2005). Risperidone for the core symptom domains of autism: Results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry, 162, 1142\u20131148.","journal-title":"The American Journal of Psychiatry"},{"key":"234_CR21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00004583-199804000-00014","volume":"37","author":"R. Nicolson","year":"1998","unstructured":"Nicolson, R., Awad, G., & Sloman, L. (1998). An open trial of risperidone in young autistic children. Journal of the American Academy of Child and Adolescent Psychiatry, 37, 372\u2013376.","journal-title":"Journal of the American Academy of Child and Adolescent Psychiatry"},{"key":"234_CR22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/hrp_8.2.45","volume":"8","author":"D. J. Posey","year":"2000","unstructured":"Posey, D. J., & McDougle, C. J. (2000). The pharmacotherapy of target symptoms associated with autistic disorder and other pervasive developmental disorders. Harvard Review of Psychiatry, 8, 45\u201363.","journal-title":"Harvard Review of Psychiatry"},{"key":"234_CR23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1176\/appi.ajp.163.3.402","volume":"163","author":"M. Reyes","year":"2006","unstructured":"Reyes, M., Buitelaar, J., Toren, P., Augustyns, I., & Eerdekens, M. (2006). A randomized, double-blind, placebo-controlled withdrawal study of risperidone in maintenance treatment of children and adolescents with disruptive behaviour disorder. American Journal of Psychiatry, 163, 402\u2013410.","journal-title":"American Journal of Psychiatry"},{"key":"234_CR24","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/BF02408436","volume":"10","author":"E. Schopler","year":"1980","unstructured":"Schopler, E., Reichler, R. J., DeVellis, R. F., & Daly, K. (1980). Toward objective classification of childhood autism: Childhood Autism Rating Scale (CARS). Journal of Autism and Developmental Disorders, 10, 91\u2013103.","journal-title":"Journal of Autism and Developmental Disorders"},{"key":"234_CR25","doi-asserted-by":"crossref","first-page":"e634","DOI":"10.1542\/peds.2003-0264-F","volume":"114","author":"S. Shea","year":"2004","unstructured":"Shea, S., Turgay, A., Carroll, A., Schulz, M., Orlik, H., Smith, I., & Dunbar, F. (2004). Risperidone in the treatment of disruptive behavioral symptoms in children with autistic and other pervasive developmental disorders. Pediatrics, 114, e634\u2013e641.","journal-title":"Pediatrics"},{"key":"234_CR26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1093\/jpepsy\/10.2.215","volume":"10","author":"S. Sparrow","year":"1985","unstructured":"Sparrow, S., & Cicchetti, D. (1985). Diagnostic uses of the Vineland Adaptive Behavior Scales. Journal of Pediatric Psychology, 10, 215\u2013225.","journal-title":"Journal of Pediatric Psychology"},{"key":"234_CR27","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0891-4222(95)00037-2","volume":"17","author":"M. J. Tass\u00e9","year":"1996","unstructured":"Tass\u00e9, M. J., Aman, M. G., & Rojahn, J. (1996). The Nisonger Child Behavior Rating Form: Age and gender effects and norms. Research in Developmental Disabilities, 17, 59\u201375.","journal-title":"Research in Developmental Disabilities"},{"key":"234_CR28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1001\/jama.289.1.49","volume":"289","author":"M. Yeargin-Allsopp","year":"2003","unstructured":"Yeargin-Allsopp, M., Rice, C., Karapurkar, T., Doernberg, N., Boyle, C., & Murphy, C. (2003). Prevalence of autism in a US metropolitan area. JAMA: The Journal of the American Medical Association, 289, 49\u201355.","journal-title":"JAMA: The Journal of the American Medical Association"}],"container-title":["Journal of Autism and Developmental Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-006-0234-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10803-006-0234-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10803-006-0234-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:52:31Z","timestamp":1559263951000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10803-006-0234-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,4]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2,22]]}},"alternative-id":["234"],"URL":"https:\/\/doi.org\/10.1007\/s10803-006-0234-7","relation":{},"ISSN":["0162-3257","1573-3432"],"issn-type":[{"value":"0162-3257","type":"print"},{"value":"1573-3432","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,4]]}}}